Oligometastatic Disease Clinical Trial
Official title:
Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma: A Multicenter, Open-Label, Phase II Trial (NPC-CR01)
The purpose of this study is to explore the efficacy and tolerance of local consolidative radiotherapy combined with Camrelizumab and chemotherapy in patients with oligometastatic nasopharyngeal carcinoma
This trial was a single-arm, multicenter phase Ⅱ clinical study. Eligible oligometastatic NPC patients were scheduled to evaluate the efficacy and tolerance of local consolidative radiotherapy combined with camrelizumab and chemotherapy in patients with oligometastatic NPC. Progression-free survival (PFS) determined will be the primary outcome measures. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06190782 -
Local Therapy for Oligometastatic Esophageal Squamous Cell Cancer Patients Treated With PD-1 Inhibitor: a Prospective, Randomized, Phase III Clinical Trial.
|
Phase 3 | |
| Not yet recruiting |
NCT06373497 -
Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography
|
Early Phase 1 | |
| Recruiting |
NCT05377047 -
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer
|
N/A | |
| Recruiting |
NCT05223803 -
TERPS Trial for de Novo Oligometastic Prostate Cancer
|
Phase 2 | |
| Recruiting |
NCT04617457 -
Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas
|
Phase 2 | |
| Recruiting |
NCT04821765 -
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
|
Phase 2 | |
| Recruiting |
NCT05679427 -
Ablative Radiosurgery vs Stereotactic RT in 5 Fractions With SIB for Oligometastatic Bone Lesions
|
N/A | |
| Recruiting |
NCT05277844 -
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
|
Phase 2 | |
| Active, not recruiting |
NCT05951127 -
Additional Consolidative Esophagectomy for the Patients With Oligometastatic Resectable ESCC
|
N/A | |
| Active, not recruiting |
NCT05101824 -
Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease
|
N/A | |
| Recruiting |
NCT04748042 -
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
|
Phase 2 | |
| Not yet recruiting |
NCT06122480 -
Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
|
Phase 2 | |
| Not yet recruiting |
NCT05784428 -
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
|
N/A | |
| Recruiting |
NCT04593381 -
Efficacy and Safety of SBRT in Oligo-metastatic/Persistent/Recurrent Ovarian Cancer
|
N/A | |
| Terminated |
NCT01345539 -
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation
|
Phase 2 | |
| Recruiting |
NCT05846646 -
Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC
|
Phase 2 | |
| Recruiting |
NCT04973007 -
Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
|
Phase 4 | |
| Recruiting |
NCT05917431 -
Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC
|
Phase 2 | |
| Not yet recruiting |
NCT05903261 -
Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors
|
||
| Not yet recruiting |
NCT05375708 -
Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites
|
Phase 2 |